ExodusPoint Capital Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-7,991
| Closed | -$289K | – | 1814 |
|
|
2025
Q1 | $289K | Sell |
7,991
-79,026
| -91% | -$2.86M | ﹤0.01% | 1176 |
|
|
2024
Q4 | $3.66M | Buy |
+87,017
| New | +$3.66M | 0.03% | 493 |
|
|
2024
Q2 | – | Sell |
-38,025
| Closed | -$1.78M | – | 1757 |
|
|
2024
Q1 | $1.78M | Buy |
+38,025
| New | +$1.78M | 0.01% | 651 |
|
|
2023
Q2 | – | Sell |
-70,864
| Closed | -$2.84M | – | 2074 |
|
|
2023
Q1 | $2.84M | Buy |
+70,864
| New | +$2.84M | 0.02% | 652 |
|
|
2022
Q4 | – | Sell |
-27,980
| Closed | -$1.16M | – | 1980 |
|
|
2022
Q3 | $1.16M | Buy |
+27,980
| New | +$1.16M | 0.02% | 1018 |
|
|
2021
Q3 | – | Sell |
-31,991
| Closed | -$3.05M | – | 2454 |
|
|
2021
Q2 | $3.05M | Buy |
+31,991
| New | +$3.05M | 0.03% | 463 |
|
|
2020
Q4 | – | Sell |
-2,965
| Closed | -$244K | – | 2224 |
|
|
2020
Q3 | $244K | Buy |
+2,965
| New | +$244K | ﹤0.01% | 1330 |
|